PSA levels appear to be more predictive of three year risk in African-American men compared with Caucasian men with a family history of , according to a paper published in Cancer Prevention Research, a journal of the American Association for Cancer Research.Cancer Prevention Research...
The initial goal of prostate cancer screening with prostate-specific antigen (PSA) was to identify men with early-stage disease according to the general oncologic principle of secondary prevention that early diagnosis and treatment would prevent disease progression and improve survival. However, 2 ...
PSA levels within 2 years of diagnosis do not predict lethal prostate cancer outcomesBecause of the excellent prognosis for localized prostate cancer in patients who remain untreated, early radical surgery might be unnecessary in most cases. Little is known about early indicators that might predict ...
Prevalence of Prostate Cancer Among Men with Normal PSA LevelsProstate CancerNew England Journal of Medicine
Your Gleason score is an important part of how your doctor will assess how likely your cancer is to grow and spread. They'll consider your Gleason score along with other factors, like your PSA levels, your PSA levels over time, physical exam findings, and tumor imaging if you need it. ...
Beyond lowering cholesterol, statin medications have been found to have numerous other health benefits, including lowering a healthy man's risk of developing advanced prostate cancer, as well as lowering his prostate-specific antigen (PSA) levels.
The ratio of your free PSAs to your overall PSA levels can give a better picture about your prostate cancer risk. The amount of free PSA is lower in men who have prostate cancer. That’s the opposite of total PSA, high levels of which can be a sign of cancer. In two men with ident...
A UCLA-led study has found treatments that reduce the risk of being diagnosed with a cancer recurrence based on rising prostate-specific antigen (PSA) levels after radiotherapy, commonly referred to as biochemical recurrence, do not necessarily improve a patient's long-term overall survival. ...
PI-RADS v2.1 and PSAD for the prediction of clinically significant prostate cancer among patients with PSA levels of 4–10ng/ml This study intended to evaluate the diagnostic accuracy of the prostate imaging reporting and data system (PI-RADS) and prostate-specific antigen density (... J Wen...
Triage of low-risk prostate cancer patients with PSA levels 10 ng/ml or less: comparison of apparent diffusion coefficient value and transrectal ultrasound-... Ryo,Itatani,Tomohiro,... - AJR: American Journal of Roentgenology : Including Diagnostic Radiology, Radiation Oncology, Nuclear Medicine, ...